CTLA4 and pancreatitis: The median time from immunotherapy initiation to the onset of pancreatitis ranges from 2 to 5 months (69 days for CTLA-4 inhibitor, 146 days for PD-1/PD-L1 inhibitor, and 110 days for combination therapy) [53].